Barbara Fallowfield, Mologic’s Commercial Manager, will be attending the 2017 National Kidney Federation Annual Conference.
This year entitled “Kidney Patients UK” the conference will be held at Hinckley Island Hotel, Leicestershire, from the 13th – 15th October.
Barbara will be there promoting PERiPLEX.
PERiPLEX is an infection test for peritoneal dialysis users, which has been developed by Mologic Scientists and recently gained CE-Mark approval.
The availability of this simple to use test will make a big difference to patients’ lives.
For more details about our PERiPLEX test, click the images or link below:
Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.
Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.